Effectiveness of Vedolizumab Induction Therapy in IBD Patients

被引:0
|
作者
Kaymak, Tanay [1 ]
Niess, Jan H. [1 ]
Hruz, Petr [1 ]
机构
[1] Univ Hosp Basel, Dept Gastroenterol & Hepatol, Basel, Switzerland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PG14
引用
收藏
页码:16S / 16S
页数:1
相关论文
共 50 条
  • [21] Comparative safety and effectiveness of tumor necrosis factor α antagonists and vedolizumab in elderly IBD patients: a multicentre study
    Adar, Tomer
    Faleck, David
    Sasidharan, Saranya
    Cushing, Kelly
    Borren, Nienke Z.
    Nalagatla, Niharika
    Ungaro, Ryan
    Sy, Wayne
    Owen, Samuel C.
    Patel, Anish
    Cohen, Benjamin L.
    Ananthakrishnan, Ashwin N.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 49 (07) : 873 - 879
  • [22] EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB (VDZ) IN IBD PATIENTS: A MULTICENTRE EXPERIENCE OF 'REAL WORLD DATA' FROM THE UK
    Lenti, M. V.
    Levison, S.
    Eliadou, E.
    Willert, R. Robert
    Kemp, K.
    Stansfield, C.
    Assadsangabi, A.
    Singh, S.
    Crooks, B.
    Tattersall, S.
    Kenneth, C.
    Subramanian, S.
    Probert, C.
    Storey, D.
    Gregg, B.
    Smith, P.
    Liu, E.
    Limdi, J. K.
    Johnston, A.
    Hamlin, P. J.
    Selinger, C. P.
    GUT, 2017, 66 : A157 - A158
  • [23] Effectiveness and Safety of Vedolizumab (VDZ) in IBD Patients: A Multicenter Experience of "Real World Data" From the UK
    Lenti, Marco Vincenzo
    Levison, Scott
    Eliadou, Elena
    Willert, Robert
    Kemp, Karen
    Stansfield, Catherine
    Assadsangabi, Arash
    Singh, Salil
    Crooks, Ben
    Tattersall, Suzanne
    Kenneth, Catherine
    Subramanian, Sreedhar
    Probert, Christopher
    Storey, Daniel
    Gregg, Belle
    Smith, Paul
    Liu, Eleanor
    Johnston, Alexander
    Hamlin, John
    Limdi, Jimmy
    Selinger, Christian
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S381 - S381
  • [24] Real-world use and 6-month effectiveness of vedolizumab subcutaneous in IBD patients: results of the VEDO-IBD study
    Plachta-Danielzik, S.
    Bokemeyer, B.
    Efken, P.
    Mohl, W.
    Hoffstadt, M.
    Krause, T.
    Schweitzer, A.
    Schnoy, E.
    Ehehalt, R.
    Trentmann, L.
    Teich, N.
    Atreya, R.
    Franzenburg, S.
    Hartmann, P.
    Wenske, T.
    Schreiber, S.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 918 - 919
  • [25] Integrin Calculus: The Predictive Power of Vedolizumab Concentrations in IBD Therapy
    Konstantinos Papamichael
    Adam S. Cheifetz
    Digestive Diseases and Sciences, 2019, 64 : 1397 - 1398
  • [26] Immunogenicity of the Influenza Vaccine in IBD Patients Treated with Vedolizumab
    Harrington, Jill E.
    Hamilton, Rachael E.
    Wasan, Sharmeel K.
    Farraye, Francis A.
    Ganley-Leal, Lisa
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S407 - S408
  • [27] Integrin Calculus: The Predictive Power of Vedolizumab Concentrations in IBD Therapy
    Papamichael, Konstantinos
    Cheifetz, Adam S.
    DIGESTIVE DISEASES AND SCIENCES, 2019, 64 (06) : 1397 - 1398
  • [28] Vedolizumab and anti-TNFα treatment effectiveness in patients with IBD treated in Germany: a retrospective chart review
    Ehehalt, R.
    Schubert, S.
    Stein, D.
    Lambrelli, D.
    Bassel, M.
    Orzechowski, H. -D.
    Minda, K.
    Khalid, M.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S39 - S40
  • [29] Efficacy of continued vedolizumab therapy in patients with Crohn's disease who did not respond to vedolizumab induction therapy at week 6
    Sandborn, W. J.
    Feagan, B.
    Reinisch, W.
    Smyth, M.
    Xu, J.
    Parikh, A.
    Fox, I.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S274 - S275
  • [30] OUTCOME OF PREGNANCIES IN VEDOLIZUMAB TREATED FEMALE IBD PATIENTS
    Moens, Annick
    van Hoeve, Karen
    Humblet, Evelien
    Rahier, Jean-Francois
    Bossuyt, Peter
    Dewit, Sophie
    Franchimont, Denis
    Elisabeth, Macken
    Nijs, Jochen
    Posen, Annelies
    Van Hootegem, Anneleen
    Van Moerkercke, Wouter
    Vermeire, Severine
    Ferrante, Marc
    GASTROENTEROLOGY, 2018, 154 (06) : S360 - S360